Who Owns Aytu BioPharma Stock?
NASDAQ: AYTUHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 35.51%
- Held by insiders
- 8.16%
- Institutional holders
- 45
- Institutions 35.5%
- Insiders 8.2%
- Public and other 56.3%
Who owns Aytu BioPharma stock?
Institutional investors own about 35.5% of Aytu BioPharma's shares, spread across 45 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 8.16% of AYTU.
The largest institutional holders are Nantahala Capital Management, LLC (10.00%), Stonepine Capital Management, LLC (8.40%) and AWM Investment Company, Inc. (5.70%). Together, the top 10 institutions control 33.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their AYTU positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of AYTU
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Nantahala Capital Management, LLC | 1.09M | 10.00% | 0.0% |
| Stonepine Capital Management, LLC | 912.92K | 8.40% | +15.2% |
| AWM Investment Company, Inc. | 619.57K | 5.70% | 0.0% |
| Vanguard Capital Management LLC | 261.15K | 2.40% | 0.0% |
| Crown Advisors Management, Inc. | 200.00K | 1.84% | +37.9% |
| Diadema Partners LP | 148.55K | 1.37% | -57.9% |
| Two Sigma Investments, LP | 105.33K | 0.97% | -13.7% |
| Renaissance Technologies, LLC | 104.82K | 0.96% | +11.8% |
| Geode Capital Management, LLC | 93.65K | 0.86% | +1.1% |
| Citadel Advisors Llc | 49.41K | 0.45% | +34.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of AYTU
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 169.00K | 1.56% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 92.15K | 0.85% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 48.91K | 0.45% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 14.10K | 0.13% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 9.76K | 0.09% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Vector Equity Portfolio | 5.48K | 0.05% |
| Dimensional ETF Trust-Dimensional US Sustainability Core 1 ETF | 4.80K | 0.04% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Sustainability Core 1 PORT. | 4.64K | 0.04% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 4.40K | 0.04% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 4.12K | 0.04% |
Frequently asked questions
Who is the largest shareholder of Aytu BioPharma?
Nantahala Capital Management, LLC is the largest institutional shareholder of AYTU, owning 10.00% of shares outstanding (1.09M shares) as of its latest 13F filing.
What percentage of Aytu BioPharma is owned by institutions?
Institutions own about 35.5% of AYTU shares and 38.7% of the public float.
How much of Aytu BioPharma do insiders own?
Insiders, such as officers and directors, own about 8.16% of AYTU shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.